-+ 0.00%
-+ 0.00%
-+ 0.00%

Roth Capital Reiterates Buy on Cingulate, Lowers Price Target to $9

Benzinga·08/24/2026 17:05:56
Listen to the news
Roth Capital analyst Boobalan Pachaiyappan reiterates Cingulate (NASDAQ:CING) with a Buy and lowers the price target from $10 to $9.